Reading between the (Genetic) Lines: How Epigenetics is Unlocking Novel Therapies for Type 1 Diabetes
<p dir="ltr">Type 1 diabetes (T1D) is an autoimmune condition where the body’s immune cells destroy their insulin-producing pancreatic beta cells leading to dysregulated glycaemia. Individuals with T1D control their blood glucose through exogenous insulin replacement therapy, often u...
Saved in:
| Main Author: | Ammira-Sarah AL-Shabeeb Akil (18949477) (author) |
|---|---|
| Other Authors: | Laila F. Jerman (18949480) (author), Esraa Yassin (11618606) (author), Sujitha S. Padmajeya (14152698) (author), Alya Al-Kurbi (18543970) (author), Khalid A. Fakhro (3158862) (author) |
| Published: |
2020
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beyond genetics: Exploring the role of epigenetic alterations in breast cancer
by: Kirti S. Prabhu (4246144)
Published: (2024) -
Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
by: Reem Saleh (3513056)
Published: (2020) -
Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
by: Gulab Sher (12984698)
Published: (2022) -
Epigenetic Regulations of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway
by: Sabah, Akhtar
Published: (2020) -
Anti-neoplastic Effect of Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid on U937 Acute Myeloid Leukemia Cell Line
by: Babikian, Patil
Published: (2020)